Exclusive

CytoSorbents Cuts Debt To $12.25 Mln Through Stock Financing And Avenue Agreement; Stock Down

India, Nov. 20 -- CytoSorbents Corporation (CTSO,HQE1.F) announced a $6.25 million common stock financing and a concurrent restructuring of its credit facility with Avenue Capital Group. The transacti... Read More


Wiz Khalifa To Headline MJBizCon 2026 With Keynote, Live Concert

India, Nov. 20 -- MJBizCon, the influential B2B cannabis Conference and Expo, has announced Grammy-nominated artist and Khalifa Kush Co-Founder, Wiz Khalifa, as keynote speaker and concert headliner o... Read More


Kingwisoft Technology Group Co Ltd. H1 Loss Climbs

India, Nov. 20 -- Kingwisoft Technology Group Co Ltd. (8295.HK) revealed Loss for its first half of -RMB55.94 million The company's earnings totaled -RMB55.94 million, or -RMB0.0117 per share. This c... Read More


Yeebo (International Holdings) Ltd Announces Rise In H1 Bottom Line

India, Nov. 20 -- Yeebo (International Holdings) Ltd (0259.HK) reported a profit for its first half that Increased, from the same period last year The company's bottom line came in at HK$2.284 billio... Read More


FDA Agrees To Annovis Bio's Safety Data Integration Plan Ahead Of Buntanetap NDA; Stock Up

India, Nov. 20 -- Friday, Annovis Bio, Inc. (ANVS) announced that the U.S. Food and Drug Administration (FDA) has agreed to its Integrated Summary of Safety (ISS) plan for buntanetap, an investigation... Read More


U.S. Consumer Sentiment Improves More Than Previously Estimated November

India, Nov. 20 -- A report released by the University of Michigan on Friday showed consumer sentiment in the U.S. improved by more than previously estimated in the month of November. The University o... Read More


MEDIROM Appeals Nasdaq Delisting Notice, Files FY25 Overdue Annual Report

India, Nov. 20 -- MEDIROM Healthcare Technologies Inc. (MRM) Wednesday said that it appealed a Nasdaq delisting determination and filed its overdue 2025 annual report on November 18. The company rece... Read More


Johnson & Johnson's TREMFYA Meets Key Endpoints In First Dedicated Phase 4 Axial PsA Study

India, Nov. 20 -- Friday, Johnson & Johnson (JNJ) announced positive results from its Phase 4 STAR study of TREMFYA (guselkumab) in adults with active psoriatic arthritis (PsA) affecting the spine. Th... Read More


Capricor Plunges On Regulatory Setback As FDA Declines To Approve Deramiocel For Duchenne

India, Nov. 20 -- Shares of Capricor Therapeutics (CAPR) plunged over 70% to $1.63 in after-hours trading on Friday, following disappointing regulatory news related to its lead investigational asset, ... Read More


Weekly Buzz: SNY, REGN Score Approvals; MIST Cuts Costs; ABBV, LLY, JNJ Strike Deals

India, Nov. 20 -- This week's biotech roundup features significant regulatory milestones, corporate restructuring and strategic dealmaking, alongside clinical developments across oncology, neurology, ... Read More